Activ Surgical, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$433Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
255clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2021 $31K
2022 $185K
2023 $82K
2024 $48K
2025 $87K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Surgery $245K
Colon & Rectal Surgery $132K
Urology $27K
Medical Oncology $9,750
Gynecologic Oncology $8,427
Internal Medicine $2,780

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Adrian Park Hagerstown, MD Surgery $208,691.65
Steven Wexner Weston, FL Colon & Rectal Surgery $61,923.41
Roger Hsiung Las Vegas, NV Colon & Rectal Surgery $40,700.00
Arun Rai Houston, TX Urology $21,449.12
Vipul Patel Ocala, FL Medical Oncology $9,750.00
Deborah Keller Scottsdale, AZ Colon & Rectal Surgery $9,288.99
Ricardo Estape Miami, FL Gynecologic Oncology $8,395.01
Matthew Kalady Columbus, OH Colon & Rectal Surgery $6,915.93
Brian Carmine Boston, MA Surgery $6,250.00
Amin Madani New York, NY Surgery $5,074.88

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.